Improving blood pressure control in patients with diabetes mellitus and high cardiovascular risk

International Journal of Hypertension

Volumn 2010, Issue , 2010, Pages

  Elliott, Henry L ^a   Lloyd, Suzanne M ^b   Ford, Ian ^b   Meredith, Peter A ^c  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INSULIN; METFORMIN; NIFEDIPINE; PLACEBO; SULFONYLUREA;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PROCEDURE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; STABLE ANGINA PECTORIS; TREATMENT OUTCOME;

EID: 84868293605     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.4061/2010/490769     Document Type: Article

References (23)

1. National Institute for Clinical Excellence, 2002, Inherited clinical guideline H. Management of type 2 diabetes. Management of blood pressure and blood lipids
2. Beckman J. A., Creager M. A., Libby P., Diabetes and atherosclerosis epidemiology, pathophysiology, and management. Journal of the American Medical Association 2002 287 19 2570 2581 2-s2.0-0037092995 (Pubitemid 34517204)
3. Hansson L., Zanchetti A., Carruthers S. G., Dahlöf B., Elmfeldt D., Julius S., Ménard J., Rahn K. H., Wedel H., Westerling S., Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998 351 9118 1755 1762 10.1016/S0140-6736(98)04311-6 (Pubitemid 28269185)
4. UK Prospective Diabetes Study Group, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. British Medical Journal 1998 317 703 713
5. Williams B., Poulter N. R., Brown M. J., Davis M., McInnes G. T., Potter J. F., Sever P. S., Thom S. M., Guidelines for management of hypertension: report of the fourth working party of the Bristish Hypertension Society, 2004BHS IV. Journal of Human Hypertension 2004 18 3 139 185 2-s2.0-1542432170 10.1038/sj.jhh.1001683 (Pubitemid 38425770)
6. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., Grassi G., Heagerty A. M., Kjeldsen S. E., Laurent S., Narkiewicz K., Ruilope L., Rynkiewicz A., Schmieder R. E., Boudier H. A. J. S., Zanchetti A., 2007 guidelines for the management of arterial hypertension. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC). Journal of Hypertension 2007 25 6 1105 1187 2-s2.0-34250350040 10.1097/HJH.0b013e3281fc975a (Pubitemid 46924065)
7. American Diabetes Association, VI. Prevention and Management of Diabetes Complications. Diabetes Care 2009 32 supplement 1 S28 S37
8. UK Prospective Diabetes Study Group, Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. British Medical Journal 1998 317 7160 713 720
9. Estacio R. O., Jeffers B. W., Hiatt W. R., Biggerstaff S. L., Gifford N., Schrier R. W., The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. New England Journal of Medicine 1998 338 10 645 652 2-s2.0-0032485350 10.1056/NEJM199803053381003 (Pubitemid 28108434)
10. Tatti P., Pahor M., Byington R. P., Di Mauro P., Guarisco R., Strollo G., Strollo F., Outcome results of the fosinopril versus amlodipine cardiovascular events randomized trial (FACET) in patients with hypertension and NIDDM. Diabetes Care 1998 21 4 597 603 2-s2.0-0031944128 10.2337/diacare.21.4.597 (Pubitemid 28172941)
11. Heart Outcomes Prevention Evaluation Study Investigators, Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000 355 9200 253 259 10.1016/S0140-6736(99)12323-7 (Pubitemid 30068516)
12. Patel A., MacMahon S., Chalmers J., Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007 370 9590 829 840 10.1016/S0140-6736(07)61303-8 (Pubitemid 47362321)
13. Poole-Wilson P. P. A., p.poole-wilson@imperial.ac.uk Lubsen P. J., Kirwan B. -A., Van Dalen F. J., Wagener G., Danchin P. N., Just P. H., Fox P. K.A.A., Pocock P. S.J., Clayton T. C., Motro P. M., Parker P. J.D., Bourassa M. G., Dart P. A.M., Hildebrandt P., Hjalmarson P. A., Kragten J. A., Molhoek G. P., Otterstad J. -E., Seabra-Gomes R., Soler-Soler P. J., Weber P. S., Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. Lancet 2004 364 9437 849 857 10.1016/S0140-6736(04)16980-8 (Pubitemid 39221062)
14. Lubsen J., jlubsen@compuserve.com Vokó Z., Poole-Wilson P. A., Kirwan B. -A., de Brouwer S., Blood pressure reduction in stable angina by nifedipine was related to stroke and heart failure reduction but not to coronary interventions. Journal of Clinical Epidemiology 2007 60 7 720 726 10.1016/j.jclinepi.2006.10.015 (Pubitemid 46891760)
15. Parmley W. W., Nesto R. W., Singh B. N., Attenuation of the circadian patterns of myocardial ischaemia with nifedipine GITS in patients with chronic stable angina. Journal of the American College of Cardiology 1992 19 1380 1389
16. Brown M. J., Palmer C. R., Castaigne A., De Leeuw P. W., Mancia G., Rosenthal T., Ruilope L. M., Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000 356 9227 366 372 2-s2.0-0034729993 (Pubitemid 30487492)
17. Lubsen J., Poole-Wilson P. A., Pocock S. J., Van Dalen F. J., Baumann J., Kirwan B. A., Parker A. B., Design and current status of ACTION: a coronary disease trial investigating outcome with nifedipine GITS. European Heart Journal 1998 19 supplement 1 I20 I32 2-s2.0-0031857247 (Pubitemid 28359348)
18. Cheung B. M. Y., Ong K. L., Cherny S. S., Sham P. C., Tso A. W. K., Lam K. S. L., Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. American Journal of Medicine 2009 122 5 443 453 2-s2.0-64349083605 10.1016/j.amjmed.2008.09.047
19. Nissen S. E., Tuzcu E. M., Libby P., Thompson P. D., Ghali M., Garza D., Berman L., Shi H., Buebendorf E., Topol E. J., Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure. The CAMELOT study: a randomized controlled trial. Journal of the American Medical Association 2004 292 18 2217 2226 2-s2.0-7744231805 10.1001/jama.292.18.2217 (Pubitemid 39473159)
20. Maneia G., Laurent S., Agabiti-Rosei E., Ambrosioni E., Burnier M., Caulfield M. J., Cifkova R., Clément D., Coca A., Dominiczak A., Erdine S., Fagard R., Farsang C., Grassi G., Haller H., Heagerty A., Kjeldsen S. E., Kiowski W., Mallion J. M., Manolis A., Narkiewicz K., Nilsson P., Olsen M. H., Rahn K. H., Redon J., Rodicio J., Ruilope L., Schmieden R. E., Struijker-Boudier H. A. J., Van Zwieten P. A., Viigimaa M., Zanchetti A., Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Journal of Hypertension 2009 27 11 2121 2158 2-s2.0-70449851433 10.1097/HJH.0b013e328333146d
21. Heart Outcomes Prevention Evaluation Study Investigators, Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. New England Journal of Medicine 2000 342 3 145 153 10.1056/NEJM200001203420301 (Pubitemid 30051645)
22. Yui Y., Shinoda E., Kodama K., Hirayama A., Nonogi H., Haze K., Sumiyoshi T., Hosoda S., Kawai C., Kawai C., Yui Y., Hosoda S., Iimura O., Ish M. II, Saruta T., Arakawa K., Shibata J., Kanmatsuse K., Motomiya T., Yabe Y., Takatsu F., Haze K., Minamino T., Satoh H., Kodama K., Hirayama A., Nonogi H., Sumiyoshi T., Shinoda E., Yui Y., Origasa H., Kato K., Nakashima M., Hattori R., Morishita H., Nifedipine retard prevents hospitalization for angina pectoris better than angiotensin-converting enzyme inhibitors in hypertensive Japanese patients with previous myocardial infarction (JMIC-B substudy). Journal of Hypertension 2007 25 10 2019 2026 2-s2.0-34748883765 10.1097/HJH. 0b013e32829c6908 (Pubitemid 47476297)
23. Elliott H. L., Meredith P. A., Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade: further analysis of the 'ACTION' database in patients with angina. Journal of Human Hypertension 2010 25 63 70 2-s2.0-77149152521 10.1038/jhh.2010.19